International Journal of Ophthalmic PathologyISSN: 2324-8599

Reach Us +1 850 900 2634
All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

Research Article, Int J Ophthalmic Pathol Vol: 3 Issue: 3

Treatment of Macular Edema Secondary to Retinal Vein Occlusion with Ranibizumab or Dexamethasone - Preliminary Results

Sibel Molva*, Mounir Benzerroug, Andrei Drimbea, Nabil Taright and Solange Milazzo
Department of Ophthalmology, Université Picardie Jules Verne, Clinique Saint-Victor. 354 BdBeauville 80054 Amiens Cedex, France
Corresponding author : Sibel Molva
Department of Ophthalmology, Université Picardie Jules Verne, Clinique Saint-Victor. 354 BdBeauville 80054 Amiens Cedex 1 France
Tel: +33(0)658558596; Fax: +33(0)322824110
E-mail: [email protected]
Received: June 17, 2014 Accepted: August 05, 2014 Published: August 08, 2014
Citation: Molva S, Benzerroug M, Drimbea A, Taright N, Milazzo S (2014) Treatment of Macular Edema Secondary to Retinal Vein Occlusion with Ranibizumab or Dexamethasone - Preliminary Results. J Ophthalmic Pathol 3:3. doi:10.4172/2324-8599.1000141

Abstract

Two recent treatments exist currently for macular edema complicating retinal vein occlusion. However, there is no standard treatment proposed at the moment, such as no specific indications for choosing one or the other treatment. To the best of our knowledge, our study is the first one published that directly compares Ranibizumab with Dexamethasone.

Keywords: Macular edema secondary; Retinal vein occlusion; Ranibizumab; Dexamethasone

Track Your Manuscript

Share This Page